Bio-Rad Laboratories, Inc.
| Security | BIO / Bio-Rad Laboratories, Inc. |
| Insider | James Barry |
This page shows the track record and history of BARRY JAMES
insider trades in Bio-Rad Laboratories, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by James Barry in BIO / Bio-Rad Laboratories, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by James Barry in BIO / Bio-Rad Laboratories, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-04 | 623 | 330.4946 | 623 | 330.4946 | 205,898 | 730 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-09-01 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 297.8800 | -217 | -65 | 532 | ||||
| 2025-09-03 | 2025-09-01 | 4 | BARRY JAMES | BIO BIO.B | Bio-Rad A Common Stock | D | 602 | 749 | ||||||
| 2024-09-04 | 2024-09-04 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 330.4946 | -623 | -206 | 147 | ||||
| 2024-09-04 | 2024-09-03 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 334.3100 | -78 | -26 | 770 | ||||
| 2024-09-04 | 2024-09-03 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 217 | 848 | ||||||
| 2024-09-04 | 2024-09-02 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -95 | -32 | 631 | ||||
| 2024-09-04 | 2024-09-02 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 265 | 726 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -64 | -22 | 461 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 177 | 525 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -62 | -21 | 348 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 173 | 410 | ||||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 337.3200 | -90 | -30 | 237 | ||||
| 2024-09-04 | 2024-09-01 | 4 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 250 | 327 | ||||||
| 2024-05-08 | 3 | BARRY JAMES | BIO BIOB | Bio-Rad A Common Stock | D | 31 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
